GMP FirstEnergy Increased Aurora Cannabis Inc (ACB)’s Stock Rating to Buy.
A potential upside of 67.22 % would indicate PT of $15 on Aurora Cannabis Inc (ACB). GMP FirstEnergy also upped ACB’s stock to a Buy on Wednesday morning.
Ticker’s shares touched $8.97 during the last trading session after 1.12% change.Aurora Cannabis Inc. has 46.53 million shares volume, 84.63% up from normal. ACB is downtrending and has moved 10.79% since March 14, 2018. The stock underperformed the SP 500 by 15.16%.
On May, 14 is anticipated Aurora Cannabis Inc. (NYSE:ACB)’s earnings report, as reported by Faxor. Analysts forecast 25.00 % diference or $-0.05 from the $-0.04 EPS from 2018. Last quarter $-0.04 EPS was reported. Analysts forecasts 25.00 % negative EPS growth this quarter.
Aurora Cannabis Inc. produces and distributes medical cannabis products.The firm is worth $9.03 billion. It is vertically integrated and horizontally